Related Experiment Video
Updated: Sep 2, 2025

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy
Published on: January 31, 2025
Epigenetic regulation of autophagy in gastrointestinal cancers
Saeid Ghavami1, Mozhdeh Zamani2, Mazaher Ahmadi3
1Department of Human Anatomy and Cell Science, Rady Faculty of Health Sciences, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada; Autophagy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran; Research Institute of Hematology and Oncology, Cancer Care Manitoba, Winnipeg, MB R3E 0V9, Canada; Faculty of Medicine in Zabrze, University of Technology in Katowice, Academia of Silesia, 41-800 Zabrze, Poland.
Abstract:
The development of novel therapeutic approaches is necessary to manage gastrointestinal cancers (GICs). Considering the effective molecular mechanisms involved in tumor growth, the therapeutic response is pivotal in this process. Autophagy is a highly conserved catabolic process that acts as a double-edged sword in tumorigenesis and tumor inhibition in a context-dependent manner. Depending on the stage of malignancy and cellular origin of the tumor, autophagy might result in cancer cell survival or death during the GICs' progression. Moreover, autophagy can prevent the progression of GIC in the early stages but leads to chemoresistance in advanced stages. Therefore, targeting specific arms of autophagy could be a promising strategy in the prevention of chemoresistance and treatment of GIC. It has been revealed that autophagy is a cytoplasmic event that is subject to transcriptional and epigenetic regulation inside the nucleus. The effect of epigenetic regulation (including DNA methylation, histone modification, and expression of non-coding RNAs (ncRNAs) in cellular fate is still not completely understood. Recent findings have indicated that epigenetic alterations can modify several genes and modulators, eventually leading to inhibition or promotion of autophagy in different cancer stages, and mediating chemoresistance or chemosensitivity. The current review focuses on the links between autophagy and epigenetics in GICs and discusses: 1) How autophagy and epigenetics are linked in GICs, by considering different epigenetic mechanisms; 2) how epigenetics may be involved in the alteration of cancer-related phenotypes, including cell proliferation, invasion, and migration; and 3) how epidrugs modulate autophagy in GICs to overcome chemoresistance.
Insights
Targeting autophagy and epigenetics in gastrointestinal cancers (GICs) offers new therapeutic strategies. Understanding these links can help overcome chemoresistance and improve GIC treatment outcomes.
Area of Science:
- Oncology
- Molecular Biology
- Epigenetics
Background:
- Gastrointestinal cancers (GICs) require novel therapeutic strategies.
- Autophagy plays a dual role in GIC progression, promoting survival or death.
- Autophagy can inhibit early-stage GIC but induce chemoresistance in advanced stages.
Purpose of the Study:
- To review the intricate links between autophagy and epigenetics in GICs.
- To explore how epigenetic mechanisms regulate autophagy in GICs.
- To discuss the potential of targeting autophagy via epigenetic drugs to treat GICs and overcome chemoresistance.
Main Methods:
- Literature review focusing on the interplay of autophagy and epigenetics in GICs.
- Analysis of epigenetic mechanisms (DNA methylation, histone modification, ncRNAs) influencing autophagy.
- Examination of how epigenetic alterations affect cancer phenotypes and chemoresistance.
Main Results:
- Epigenetic regulation influences autophagy, impacting GIC progression and chemoresistance.
- Epigenetic modifications can alter cancer cell proliferation, invasion, and migration.
- Epidrugs show potential in modulating autophagy to enhance GIC treatment efficacy.
Conclusions:
- The interplay between autophagy and epigenetics is crucial in GIC development and chemoresistance.
- Targeting epigenetic regulation of autophagy presents a promising therapeutic avenue for GICs.
- Further research into epidrugs modulating autophagy could lead to improved GIC treatment strategies.
Related Concept Videos
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Epigenetic Regulation
X-chromosome...
Delivery Pathways to the Lysosome
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...

